96. クローン病 Crohn disease Clinical trials / Disease details

臨床試験数 : 2,400 / 薬物数 : 1,391 - (DrugBank : 267) / 標的遺伝子数 : 170 - 標的パスウェイ数 : 215

27 trials found

diseases per page:

Showing 1 to 10 of 27 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-002687-27-HR (EUCTR)	10/03/2022	14/03/2022	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India ...
2	EUCTR2019-002687-27-LT (EUCTR)	03/09/2021	29/06/2021	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India ...
3	JPRN-jRCT2031210210	16/08/2021	28/07/2021	A Study of Mirikizumab(LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disea ...	A master protocol for a Phase 3, multicenter, open-label, long-term extension study to evaluate the ...	Ulcerative Colitis / Crohn's Disease -	Drug: Mirikizumab Administered SC Other Name: LY3074828	Yoshimoto Yusuke	NULL	Recruiting	Not applicable	Not applicable	Both	5	Phase 3	United States;Japan
4	EUCTR2019-002687-27-DE (EUCTR)	27/07/2021	13/04/2021	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India ...
5	EUCTR2019-002687-27-LV (EUCTR)	17/06/2021	11/03/2021	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	France;Australia;Denmark;Netherlands;Latvia;China;Korea, Republic of;Czechia;Turkey;Lithuania;Austri ...
6	EUCTR2019-002687-27-FR (EUCTR)	10/06/2021	04/05/2021	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India ...
7	NCT04844606 (ClinicalTrials.gov)	May 26, 2021	12/4/2021	A Master Protocol (AMAZ): A Study of Mirikizumab(LY3074828) in Pediatric Participants With Ulcerativ ...	A Master Protocol for a Phase 3, Multicenter, Open-label, Long-term Extension Study to Evaluate the ...	Ulcerative Colitis;Ulcerative Colitis Chronic;Inflammatory Bowel Diseases;Crohn's Disease	Drug: Mirikizumab	Eli Lilly and Company	NULL	Recruiting	2 Years	19 Years	All	185	Phase 3	United States;Israel;Japan;Korea, Republic of
8	EUCTR2019-002687-27-IT (EUCTR)	18/05/2021	30/07/2021	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease;Therapeutic area: Diseases [C] - Digestive System Diseases [C06]	Product Name: MIRIKIZUMAB Product Code: [LY3074828] INN or Proposed INN: MIRIKIZUMAB Product Name: MIRI ...	ELI LILLY & COMPANY, LILLY CORPORATE CENTER	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India;France ...
9	EUCTR2019-002687-27-SK (EUCTR)	25/02/2021	08/12/2020	A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease	A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and ...	Crohn´s Disease MedDRA version: 20.0;Level: PT;Classification code 10011401;Term: Crohn's disease;Sy ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	778	Phase 3	Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India ...
10	EUCTR2018-004614-18-DK (EUCTR)	08/09/2020	05/08/2019	Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Active Crohn's Disease	A Phase 3, Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled, Treat-Through Stud ...	moderately to severely active Crohn’s disease MedDRA version: 20.0;Level: PT;Classification code 100 ...	Product Name: MIRIKIZUMAB Product Code: LY3074828 INN or Proposed INN: MIRIKIZUMAB Other descriptive na ...	Eli Lilly and Company	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	1150	Phase 3	Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Switzerland;Italy;India ...

First Previous1 2 3Next Last